Developer docs
API playgroundTry for free, no card

Search company profiles

XR Therapeutics

Full company profile

uuid0002tzo

Namestring
XR Therapeutics
Legal namestring
XR Therapeutics LTD
Company typeenum
Private
Founded yearint
2020
Descriptiontext

XR Therapeutics is a UK-based digital therapeutics company, spun out of Newcastle University in July 2020, that delivers extended reality (XR) therapy combining immersive virtual reality simulations with Cognitive Behavioural Therapy (CBT) for the treatment of anxiety, phobias, PTSD, OCD, depression, and autism-related conditions. Its platform comprises a content library of over 70 therapist-controlled treatment scenes displayed on 82-inch screens or VR headsets and managed via a tablet or laptop interface, alongside the Boundless remote delivery platform launched in April 2024 that enables therapy to be conducted via telehealth. The company is regulated by the MHRA as a UKCA Class I Software as a Medical Device, holds DTAC certification for NHS clinical safety standards, and is backed by 9 years of clinical research from Newcastle University and the Cumbria, Northumberland, Tyne and Wear NHS Trust.

The company operates a hybrid B2B/B2C revenue model. B2B revenue comes from multi-year licensing and implementation contracts with NHS trusts (7 trusts, 1 ICB, and 3 charities disclosed), including a structured 6-8 week deployment process with co-design workshops, CPD UK-accredited therapist training, and ongoing support. B2C revenue comes from direct private patient bookings at £395 for an initial six-session course, with additional sessions at £70 each and PayPal instalment options. Distribution is achieved through direct enterprise field sales to NHS decision-makers, a self-serve website booking flow for private patients, and partnership channels with charities and corporate CSR programmes. The company has approximately 14-16 employees based in Gateshead, with CEO Billy Webber leading a team that includes clinical founders Dr Morag Maskey (CSO) and Professor Jeremy Parr (Director), CTO Shaun Allan, COO Penny Day, and Chief Clinical Officer Andy Morrow.

Short descriptiontext

XR Therapeutics is a UK digital therapeutics company that combines immersive extended reality simulations with CBT to treat anxiety, phobias, and related conditions, serving NHS mental health trusts, charities, and private patients through in-person therapy suites and the Boundless remote platform.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersNewcastle Upon Tyne, United Kingdom
HQ citystring
Newcastle Upon Tyne
HQ countrystring
United Kingdom
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
extended reality therapy, virtual reality mental health, digital therapeutics platform, immersive CBT software, anxiety phobia treatment
Industry1 code
PRIMARYHLACANAI
Behavioral Health & Neurocognitive Therapeutics (Digital)
Healthcare & Life Sciences/Digital Health & Health IT/Digital Therapeutics (DTx) & Software as a Medical Device (SaMD)
NAICS code2 codes
  • Offices of Physicians, Mental Health Specialists621112
  • Outpatient Mental Health and Substance Abuse Centers621420
SIC code2 codes
  • Services-Prepackaged Software7372
  • Services-Health Services8000
Product category
Digital Mental Health Therapy Software
Social media profiles1 record
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model3 records
1Private Patient Treatment
TypeSubscription Recurring
Description

Direct-to-consumer therapy sessions for private patients. Initial course of 6 sessions costs £395, with additional sessions at £70 each. First discovery session is free. Payment accepted via PayPal pay in 3 and pay later options. Health insurance accepted.

xrtherapeutics.co.uk
2NHS/Healthcare Trust Licensing
TypeSubscription Recurring
Description

B2B licensing model for NHS trusts and mental health organizations. Includes platform access, training, and ongoing support. Implementation involves co-design workshops, full training, and 6-8 week deployment timeline.

xrtherapeutics.co.uk
3Corporate/Charity Partnerships
TypeProfessional Services
Description

Partnerships with employers and charities to fund treatment for employees or beneficiaries, such as Jackson Hogg funding treatment for a child with autism.

xrtherapeutics.co.uk
Marketing channels8 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels6 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure, Others
Pricing details3 tiers
1Initial Treatment Course - £395 for 6 sessions
ModelSubscriptionBilling cadenceMulti-year contract
Notes

A short course of treatment is £395 for six sessions. Further sessions after the initial six are chargeable at £70 per session. The first discovery session is free. PayPal pay in 3 and pay later options available. Health insurance accepted (client responsible for confirming coverage).

xrtherapeutics.co.uk
23T Pioneer Programme - £5,000 saving
ModelSubscriptionBilling cadenceMulti-year contract
Notes

Talking Therapies Tech Pioneers programme for clinical leads and step 3 therapists. Includes leading on talking therapies innovation, collaborating on scene designs, and extra training and resources. Represents a £5,000 saving compared to standard pricing.

xrtherapeutics.co.uk
3Custom Business Case Implementation
ModelSubscriptionBilling cadenceMulti-year contract
Notes

Tailored solution for NHS providers across the country. Includes single use case agreed with XRT, limited co-design, full support and training, and access to Boundless platform. Pricing customized based on requirements.

xrtherapeutics.co.uk
GTM typeB2B and B2C
B2B and B2C
Offering typeSoftware
Software
Brand1 record
1Boundless
Description

A remote therapy software platform enabling XR therapy to be delivered via video call, allowing patients to receive treatment from home or any location. Launched in April 2024, Boundless expands accessibility beyond in-person studio sessions.

xrtherapeutics.co.uk
Core offering1 text field

XR Therapeutics provides immersive extended reality (XR) therapy that combines therapist-controlled virtual reality simulations with Cognitive Behavioural Therapy (CBT) to treat anxiety, phobias, PTSD, OCD, and depression. The offering is delivered via in-person Digitally Enhanced Therapy Suites (over 70 treatment scenes displayed on screens/VR headsets and controlled by a tablet) and through the Boundless remote telehealth platform, sold to NHS trusts and other healthcare organisations under licensing arrangements and directly to private patients as pay-per-course treatment.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 7 values shown
  • 94% positive outcomes, 71% reliable recovery rate
+6 more records
Product overview1 text field

XR Therapeutics operates a unified XR-enhanced mental health therapy platform comprising two primary delivery modes: the core XR Therapy service (using immersive extended reality simulations combined with CBT) and the Boundless remote software platform (launched April 2024 for telehealth delivery). The in-person delivery uses Digitally Enhanced Therapy Suites (with over 70 treatment scenes and relaxation scenes displayed on 82-inch screens, controlled via tablet). Therapist Training and implementation support services enable NHS and private sector adoption. The company was spun out from Newcastle University in July 2020 after 9 years of clinical research.

Product and service4 records
1Boundless Remote Therapy Platform
CategorySoftware as a Medical Device
Description

Software platform launched in April 2024 that enables remote XR therapy delivery via telehealth, allowing patients to receive therapist-guided immersive exposure therapy from home or any location without visiting a studio.

2XR Therapy Service
CategoryClinical Therapy Service
Description

Core XR therapy service combining immersive extended reality simulations with evidence-based CBT. Therapist-controlled digital simulations of real-world anxiety-triggering scenarios are used to treat anxiety, phobias, PTSD, depression, OCD, and autism-related conditions in adults and children.

3Digitally Enhanced Therapy Suite
CategorySoftware as a Medical Device
Description

In-person therapy delivery system comprising an 82-inch TV displaying immersive scenes, a tablet/laptop controlling the simulations, and CPD-accredited training for therapists, installed in NHS trusts, charities, and hospitals.

4CPD-Accredited Therapist Training Programme
CategoryTraining Services
Description

CPD UK-accredited training programme that teaches therapists to deliver XR therapy sessions, including in-person training by the XRT clinical team, an e-learning platform, and patient/family communication support.

Scale indicator10 records

Each record includes

Type, Value, Description, Source

Partnership11 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-09-01
Description

Partnership announced to provide cutting-edge mental health treatment to young people in south west London. XR therapy will be used to digitally simulate scenarios linked to anxieties and fears, used alongside CBT techniques. CAMHS services in Kingston, Merton, Richmond, Sutton and Wandsworth will have access to this technology.

Strategic tierCoreTypeTechnology or Integration
Description

XR Therapeutics spun out from Newcastle University after a decade of clinical research. The company was founded by Dr Morag Maskey and Professor Jeremy Parr based on their research at the university. The technology is built on 9 years of clinical research from Newcastle University and Cumbria Northumberland Tyne and Wear NHS Trust.

Strategic tierCoreTypeTechnology or Integration
Description

Clinical research partner for the development of XR therapy technology. Treatment scenes built from research conducted with this NHS trust alongside Newcastle University.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

NHS trust partner using XR therapy treatment. Features prominently in podcast discussion with Katheryn from Sheffield Children's NHS Foundation Trust about how immersive technology creates faster, more effective outcomes for patients.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

NHS trust partner providing XR therapy treatment to patients across Greater Manchester area as part of mental health service delivery.

6Jackson Hogg
Strategic tierMinorTypeGTM or Marketing Partner
Description

Jackson Hogg partnered with XR Therapeutics as part of their corporate social responsibility programme, funding anxiety treatment for a child with autism. Partnership exemplifies employer-supported mental health intervention.

xrtherapeutics.co.uk
Strategic tierMinorTypeGTM or Marketing Partner
Description

Media coverage by Northern Echo of pioneering initiative using XR therapy to help young people on probation, providing visibility for the company's work in the justice sector.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Charity partner receiving XR therapy services for beneficiaries with autism and related conditions.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Charity partner providing XR therapy treatment to children and young people with autism.

Strategic tierMinorTypeGTM or Marketing Partner
Description

Featured on Anxiety UK's 'And Breathe' podcast, hosted by David Smith, discussing XR therapy treatment with Penny from XR Therapeutics and Katheryn from Sheffield Children's NHS Foundation Trust.

11CHEATA (Centre for Healthcare Equipment and Technology Adoption)
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Nottingham University Hospitals NHS Trust division that conducted independent health economics evaluation of Boundless, modelling outcomes for GAD patients and demonstrating cost-effectiveness.

xrtherapeutics.co.uk
Recent move9 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
1XRHealth
TypeDirect peer
Description

Israel/US-based VR therapy platform delivering clinician-supervised immersive treatment for anxiety, PTSD, phobias, and chronic pain. The most directly comparable peer: both companies sell therapist-controlled XR simulations combined with CBT-style protocols to health systems and providers.

TypeDirect peer
Description

VR mental and behavioural health platform (formerly Oxford VR) building immersive therapies for anxiety, depression, chronic pain and stress. Closely aligned with XR Therapeutics on therapeutic modality (VR + CBT), target indications, and health-system go-to-market, with comparable therapist-led delivery model.

3Psious
TypeDirect peer
Description

VR therapy platform for mental health practitioners treating anxiety, phobias, OCD, and PTSD using controlled virtual environments. Direct peer because both companies market clinician-delivered, scene-based exposure therapy to therapists and clinics rather than direct-to-consumer entertainment VR.

TypeBroad incumbent
Description

Digital therapeutics company behind Sleepio (insomnia) and Daylight (worry/anxiety), offering CBT-based digital treatments prescribed via health systems, payers, and employers. Comparable as a digital mental-health DTx competitor in adjacent anxiety indications, but operates without immersive VR hardware or scenes.

TypeBroad incumbent
Description

Prescription digital therapeutic company (EndeavorRx, EndeavorOTC) with FDA-authorised cognitive treatment software. Comparable as a regulated SaMD digital therapeutics business targeting mental and cognitive health via clinicians, though focused on cognitive/ADHD rather than anxiety/phobia exposure therapy.

TypeEmerging player
Description

UK-based AI mental health platform supporting NHS talking therapies with patient-facing tools and therapist decision support. Comparable as a UK digital mental health company selling to NHS IAPT/talking therapies services, with overlapping customer base but a fundamentally different (AI/chat) modality.

TypeDirect peer
Description

UK-based online CBT provider delivering therapist-led cognitive behavioural therapy to NHS IAPT services and private patients. Comparable on target customers (NHS talking therapies), treatment modality (CBT), and clinical outcomes focus, though delivered via text-based online therapy rather than immersive XR.

TypeBroad incumbent
Description

Digital mental health platform acquired by Amwell, offering CBT-based programmes for anxiety and depression to NHS, employers and health plans. Comparable as a scaled digital CBT incumbent serving the same NHS talking therapies market, though via app/web rather than VR.

TypeEmerging player
Description

Digital therapeutics company developing prescription CBT apps for conditions including IBS and mental health. Comparable as a regulated digital therapeutics competitor pursuing similar clinical evidence-led payer routes, although without immersive XR delivery.

10Oxford VR (legacy entity) / RealizedCare
TypeEmerging player
Description

Evolution of the original Oxford VR entity into RealizedCare, offering VR-based behavioural health interventions. Peer because of shared heritage in UK-academic VR mental health research and similar target markets, despite different current product focus and go-to-market.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers8 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment5 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability4 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles16 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance5 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds3 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors3 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

XR Therapeutics

Digital Mental Health Therapy Softwarexrtherapeutics.co.uk

XR Therapeutics is a UK digital therapeutics company that combines immersive extended reality simulations with CBT to treat anxiety, phobias, and related conditions, serving NHS mental health trusts, charities, and private patients through in-person therapy suites and the Boundless remote platform.

What XR Therapeutics does

XR Therapeutics is a UK-based digital therapeutics company, spun out of Newcastle University in July 2020, that delivers extended reality (XR) therapy combining immersive virtual reality simulations with Cognitive Behavioural Therapy (CBT) for the treatment of anxiety, phobias, PTSD, OCD, depression, and autism-related conditions. Its platform comprises a content library of over 70 therapist-controlled treatment scenes displayed on 82-inch screens or VR headsets and managed via a tablet or laptop interface, alongside the Boundless remote delivery platform launched in April 2024 that enables therapy to be conducted via telehealth. The company is regulated by the MHRA as a UKCA Class I Software as a Medical Device, holds DTAC certification for NHS clinical safety standards, and is backed by 9 years of clinical research from Newcastle University and the Cumbria, Northumberland, Tyne and Wear NHS Trust.

The company operates a hybrid B2B/B2C revenue model. B2B revenue comes from multi-year licensing and implementation contracts with NHS trusts (7 trusts, 1 ICB, and 3 charities disclosed), including a structured 6-8 week deployment process with co-design workshops, CPD UK-accredited therapist training, and ongoing support. B2C revenue comes from direct private patient bookings at £395 for an initial six-session course, with additional sessions at £70 each and PayPal instalment options. Distribution is achieved through direct enterprise field sales to NHS decision-makers, a self-serve website booking flow for private patients, and partnership channels with charities and corporate CSR programmes. The company has approximately 14-16 employees based in Gateshead, with CEO Billy Webber leading a team that includes clinical founders Dr Morag Maskey (CSO) and Professor Jeremy Parr (Director), CTO Shaun Allan, COO Penny Day, and Chief Clinical Officer Andy Morrow.

XR Therapeutics firmographics

Firmographics
Name
XR Therapeutics
Legal name
XR Therapeutics LTD
Website
https://xrtherapeutics.co.uk
Company type
Private
Founded year
2020
Operating status
Operating
Headcount range
11–50 employees
Short description
XR Therapeutics is a UK digital therapeutics company that combines immersive extended reality simulations with CBT to treat anxiety, phobias, and related conditions, serving NHS mental health trusts, charities, and private patients through in-person therapy suites and the Boundless remote platform.
Ownership category
akta.pro rank

XR Therapeutics industry classification

Industry
Product category
Digital Mental Health Therapy Software
NAICS
Offices of Physicians, Mental Health Specialists (621112), Outpatient Mental Health and Substance Abuse Centers (621420)
SIC
Services-Prepackaged Software (7372), Services-Health Services (8000)
akta.pro industry
PRIMARYHLACANAI
Behavioral Health & Neurocognitive Therapeutics (Digital)
Healthcare & Life Sciences/Digital Health & Health IT/Digital Therapeutics (DTx) & Software as a Medical Device (SaMD)

Keywords

  • Extended reality therapy
  • Virtual reality mental health
  • Digital therapeutics platform
  • Immersive CBT software
  • Anxiety phobia treatment

Where XR Therapeutics is headquartered

Location

Headquarters

HQ city
Newcastle Upon Tyne
HQ country
United Kingdom
HQ region
Europe

Offices1 record

Markets served

XR Therapeutics business model

Business model
GTM type
B2B and B2C
Offering type
Software
Cost components
Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure, Others

Revenue model

  1. Private Patient Treatment: Direct-to-consumer therapy sessions for private patients. Initial course of 6 sessions costs £395, with additional sessions at £70 each. First discovery session is free. Payment accepted via PayPal pay in 3 and pay later options. Health insurance accepted.
  2. NHS/Healthcare Trust Licensing: B2B licensing model for NHS trusts and mental health organizations. Includes platform access, training, and ongoing support. Implementation involves co-design workshops, full training, and 6-8 week deployment timeline.
  3. Corporate/Charity Partnerships: Partnerships with employers and charities to fund treatment for employees or beneficiaries, such as Jackson Hogg funding treatment for a child with autism.

Pricing tiers

ModelBillingPrice
SubscriptionMulti-year contractInitial Treatment Course - £395 for 6 sessions
SubscriptionMulti-year contract3T Pioneer Programme - £5,000 saving
SubscriptionMulti-year contractCustom Business Case Implementation

Go-to-market motion3 records

Distribution channels6 records

Marketing channels8 records

XR Therapeutics product offering

Product offering

Core offering

XR Therapeutics provides immersive extended reality (XR) therapy that combines therapist-controlled virtual reality simulations with Cognitive Behavioural Therapy (CBT) to treat anxiety, phobias, PTSD, OCD, and depression. The offering is delivered via in-person Digitally Enhanced Therapy Suites (over 70 treatment scenes displayed on screens/VR headsets and controlled by a tablet) and through the Boundless remote telehealth platform, sold to NHS trusts and other healthcare organisations under licensing arrangements and directly to private patients as pay-per-course treatment.

Product overview

XR Therapeutics operates a unified XR-enhanced mental health therapy platform comprising two primary delivery modes: the core XR Therapy service (using immersive extended reality simulations combined with CBT) and the Boundless remote software platform (launched April 2024 for telehealth delivery). The in-person delivery uses Digitally Enhanced Therapy Suites (with over 70 treatment scenes and relaxation scenes displayed on 82-inch screens, controlled via tablet). Therapist Training and implementation support services enable NHS and private sector adoption. The company was spun out from Newcastle University in July 2020 after 9 years of clinical research.

Differentiator

Problem solved

Functional benefit

Brands

  • Boundless: A remote therapy software platform enabling XR therapy to be delivered via video call, allowing patients to receive treatment from home or any location. Launched in April 2024, Boundless expands accessibility beyond in-person studio sessions.

Products and services

  • Boundless Remote Therapy Platform Software platform launched in April 2024 that enables remote XR therapy delivery via telehealth, allowing patients to receive therapist-guided immersive exposure therapy from home or any location without visiting a studio.
  • XR Therapy Service Core XR therapy service combining immersive extended reality simulations with evidence-based CBT. Therapist-controlled digital simulations of real-world anxiety-triggering scenarios are used to treat anxiety, phobias, PTSD, depression, OCD, and autism-related conditions in adults and children.
  • Digitally Enhanced Therapy Suite In-person therapy delivery system comprising an 82-inch TV displaying immersive scenes, a tablet/laptop controlling the simulations, and CPD-accredited training for therapists, installed in NHS trusts, charities, and hospitals.
  • CPD-Accredited Therapist Training Programme CPD UK-accredited training programme that teaches therapists to deliver XR therapy sessions, including in-person training by the XRT clinical team, an e-learning platform, and patient/family communication support.

Quantifiable outcome

  • 94% positive outcomes, 71% reliable recovery rate
  • +6 more outcomes

Companies that use XR Therapeutics

Customer profile

Named customers8 records

Segments5 records

Ideal customer profiles3 records

XR Therapeutics technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability4 records

Feature5 records

XR Therapeutics partnerships and signals

Strategic signal

Partnerships

Eleven partnerships are on record, tiered core and minor.

  • South West London and St George's Mental Health NHS TrustcoreStrategic or Co-development Partner · 1 September 2025Partnership announced to provide cutting-edge mental health treatment to young people in south west London. XR therapy will be used to digitally simulate scenarios linked to anxieties and fears, used alongside CBT techniques. CAMHS services in Kingston, Merton, Richmond, Sutton and Wandsworth will have access to this technology.
  • Newcastle UniversitycoreTechnology or IntegrationXR Therapeutics spun out from Newcastle University after a decade of clinical research. The company was founded by Dr Morag Maskey and Professor Jeremy Parr based on their research at the university. The technology is built on 9 years of clinical research from Newcastle University and Cumbria Northumberland Tyne and Wear NHS Trust.
  • Cumbria Northumberland Tyne and Wear NHS TrustcoreTechnology or IntegrationClinical research partner for the development of XR therapy technology. Treatment scenes built from research conducted with this NHS trust alongside Newcastle University.
  • Sheffield Children's NHS Foundation TrustcoreStrategic or Co-development PartnerNHS trust partner using XR therapy treatment. Features prominently in podcast discussion with Katheryn from Sheffield Children's NHS Foundation Trust about how immersive technology creates faster, more effective outcomes for patients.
  • Greater Manchester Mental Health TrustcoreStrategic or Co-development PartnerNHS trust partner providing XR therapy treatment to patients across Greater Manchester area as part of mental health service delivery.
  • Jackson HoggminorGTM or Marketing PartnerJackson Hogg partnered with XR Therapeutics as part of their corporate social responsibility programme, funding anxiety treatment for a child with autism. Partnership exemplifies employer-supported mental health intervention.
  • Northern EchominorGTM or Marketing PartnerMedia coverage by Northern Echo of pioneering initiative using XR therapy to help young people on probation, providing visibility for the company's work in the justice sector.
  • Percy Hedley FoundationminorStrategic or Co-development PartnerCharity partner receiving XR therapy services for beneficiaries with autism and related conditions.
  • Toby Henderson TrustminorStrategic or Co-development PartnerCharity partner providing XR therapy treatment to children and young people with autism.
  • Anxiety UKminorGTM or Marketing PartnerFeatured on Anxiety UK's 'And Breathe' podcast, hosted by David Smith, discussing XR therapy treatment with Penny from XR Therapeutics and Katheryn from Sheffield Children's NHS Foundation Trust.
  • CHEATA (Centre for Healthcare Equipment and Technology Adoption)minorStrategic or Co-development PartnerNottingham University Hospitals NHS Trust division that conducted independent health economics evaluation of Boundless, modelling outcomes for GAD patients and demonstrating cost-effectiveness.

Scale indicators10 records

Recent moves9 records

Expansion highlights6 records

XR Therapeutics competitors and assessment

Company assessment

Direct peers

  • XRHealth: Israel/US-based VR therapy platform delivering clinician-supervised immersive treatment for anxiety, PTSD, phobias, and chronic pain. The most directly comparable peer: both companies sell therapist-controlled XR simulations combined with CBT-style protocols to health systems and providers.
  • BehaVR: VR mental and behavioural health platform (formerly Oxford VR) building immersive therapies for anxiety, depression, chronic pain and stress. Closely aligned with XR Therapeutics on therapeutic modality (VR + CBT), target indications, and health-system go-to-market, with comparable therapist-led delivery model.
  • Psious: VR therapy platform for mental health practitioners treating anxiety, phobias, OCD, and PTSD using controlled virtual environments. Direct peer because both companies market clinician-delivered, scene-based exposure therapy to therapists and clinics rather than direct-to-consumer entertainment VR.
  • Ieso Digital Health: UK-based online CBT provider delivering therapist-led cognitive behavioural therapy to NHS IAPT services and private patients. Comparable on target customers (NHS talking therapies), treatment modality (CBT), and clinical outcomes focus, though delivered via text-based online therapy rather than immersive XR.

Broad incumbents

  • Big Health: Digital therapeutics company behind Sleepio (insomnia) and Daylight (worry/anxiety), offering CBT-based digital treatments prescribed via health systems, payers, and employers. Comparable as a digital mental-health DTx competitor in adjacent anxiety indications, but operates without immersive VR hardware or scenes.
  • Akili Interactive: Prescription digital therapeutic company (EndeavorRx, EndeavorOTC) with FDA-authorised cognitive treatment software. Comparable as a regulated SaMD digital therapeutics business targeting mental and cognitive health via clinicians, though focused on cognitive/ADHD rather than anxiety/phobia exposure therapy.
  • SilverCloud Health (Amwell): Digital mental health platform acquired by Amwell, offering CBT-based programmes for anxiety and depression to NHS, employers and health plans. Comparable as a scaled digital CBT incumbent serving the same NHS talking therapies market, though via app/web rather than VR.

Emerging players

  • Limbic: UK-based AI mental health platform supporting NHS talking therapies with patient-facing tools and therapist decision support. Comparable as a UK digital mental health company selling to NHS IAPT/talking therapies services, with overlapping customer base but a fundamentally different (AI/chat) modality.
  • Mahana Therapeutics: Digital therapeutics company developing prescription CBT apps for conditions including IBS and mental health. Comparable as a regulated digital therapeutics competitor pursuing similar clinical evidence-led payer routes, although without immersive XR delivery.
  • Oxford VR (legacy entity) / RealizedCare: Evolution of the original Oxford VR entity into RealizedCare, offering VR-based behavioural health interventions. Peer because of shared heritage in UK-academic VR mental health research and similar target markets, despite different current product focus and go-to-market.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

XR Therapeutics social profiles

Digital presence

XR Therapeutics compliance and trust

Trust signal

Compliance5 records

XR Therapeutics financial estimates

Financial estimate

Revenue estimate

Valuation estimate

XR Therapeutics leadership team

Management profile

Number of profiles

Profiles16 records

XR Therapeutics funding detail

Funding detail

Funding overview

Funding rounds3 records

Investors3 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

XR Therapeutics M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about XR Therapeutics

What does XR Therapeutics do?

XR Therapeutics provides immersive extended reality (XR) therapy that combines therapist-controlled virtual reality simulations with Cognitive Behavioural Therapy (CBT) to treat anxiety, phobias, PTSD, OCD, and depression. The offering is delivered via in-person Digitally Enhanced Therapy Suites (over 70 treatment scenes displayed on screens/VR headsets and controlled by a tablet) and through the Boundless remote telehealth platform, sold to NHS trusts and other healthcare organisations under licensing arrangements and directly to private patients as pay-per-course treatment.

Is XR Therapeutics a public or private company?

XR Therapeutics is a private company. It is classified as venture growth investor backed and is currently operating.

When was XR Therapeutics founded?

XR Therapeutics was founded in 2020. It employs 11 to 50 people.

Where is XR Therapeutics based?

XR Therapeutics is headquartered in Newcastle Upon Tyne, United Kingdom, in the Europe region.

How does XR Therapeutics make money?

Three revenue lines are on record. Private Patient Treatment is the primary driver. The others are NHS/Healthcare Trust Licensing and corporate/Charity Partnerships.

Who are XR Therapeutics's main competitors?

Direct peers on record are XRHealth, BehaVR, Psious and Ieso Digital Health. Broad incumbents are Big Health, Akili Interactive and SilverCloud Health (Amwell). Emerging players are Limbic, Mahana Therapeutics and Oxford VR (legacy entity) / RealizedCare.

Does XR Therapeutics have an API?

No public API is recorded for XR Therapeutics.

What industry is XR Therapeutics in?

XR Therapeutics's product category is Digital Mental Health Therapy Software. Its primary akta.pro industry code is HLACANAI, Behavioral Health & Neurocognitive Therapeutics (Digital). Its NAICS code is 621112 and its SIC code is 7372.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Business LiveNorth East firms XR Therapeutics and Literal Labs make UK top startup listTwo North East companies, Gateshead-based XR Therapeutics and Newcastle-based Literal Labs, have been included in the Startups 100 Index, which identifies the UK's most promising startups demonstrating technological innovation, strong financials, and market disruption. XR Therapeutics provides virtual reality-based therapy sessions combining cognitive behavioural therapy with immersive technology for anxiety and phobias, while Literal Labs, founded by Newcastle University professors, secured £4.6m in pre-seed funding to develop sustainable and explainable AI models. The index highlights that UK entrepreneurial innovation extends beyond London, positioning the North as a growing engine of business creation.BdailyNewcastle showcases NHS digital innovationOver 170 NHS leaders and technology innovators gathered at The Catalyst in Newcastle on October 17 for the "Analogue to Digital: Delivering the NHS 10-Year Plan in the North East" event, hosted by Global Government Forum, to showcase the NHS digital transformation agenda. Sir Jim Mackey, chief executive of NHS England, delivered the keynote outlining the 10-Year Plan's ambitions, while a new report based on interviews with NHS digital leaders was launched with recommendations on multi-year digital funding, skills development, and interoperability standards. Regional innovators including XR Therapeutics, which develops immersive therapy solutions, also showcased their work at the event.htn£3.6 million Innovate UK funding granted to 17 digital mental health tools – HTN Health Tech NewsInnovate UK is granting £3.6 million to 17 supplier-led projects developing digital therapeutic solutions for mental health using extended reality (XR) technology such as virtual reality, augmented reality, mixed reality, and haptics. The funded projects address conditions including PTSD, ADHD, autism, generalised anxiety disorder, and depression, with the aim of treating more people in remote or underserved areas. Projects will be developed and trialled over 12-to-18 months with potential for adoption into the UK's formal mental healthcare ecosystem, as part of the Mindset XR for digital mental health programme.